hematopoietic prostaglandin D2 synthase inhibitors (Kyowa Kirin)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namehematopoietic prostaglandin D2 synthase inhibitors (Kyowa Kirin)
Drug Alias NameK-400
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProstaglandin-H2 D-isomerase inhibitors
TargetsProstaglandin-H2 D-isomerase
Therapy Area/IndicationsHypersensitivityAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKirin Holdings Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKirin Holdings Co Ltd
Active IndicationsN/A
Inactive IndicationsHypersensitivityAsthma

Other Information

ATC CodeN/A
Related LinksN/A